Negative regulation of epinephrine secretion

pathway activity — cross-omics
GO:0032811Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of epinephrine secretion pathway is significantly associated with the RNA expression of multiple genes, with the OV cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are SLC35F2, NAV2, and C2CD4D-AS1, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of epinephrine secretion activity versus SLC35F2 in OV (Pearson r = -0.40).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
OVSLC35F2 →-0.815-0.522<.001.00333
PDACNAV2 →-0.431-0.486<.001.00133
PDACC2CD4D-AS1 →-0.591-0.550.004.00133
GBMLDHA →-0.436-0.604.003<.00133
GBMNRSN1 →+0.829+0.777<.001<.00133
GBMNEGR1 →+0.955+0.807<.001<.00133
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0032811 vs SLC35F2 — OV

Per-sample scatter of Negative regulation of epinephrine secretion activity vs SLC35F2 in OV.

Explore this scatter interactively →

Exploration